Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.54p
   
  • Change Today:
      0.013p
  • 52 Week High: 1.85
  • 52 Week Low: 0.52
  • Currency: UK Pounds
  • Shares Issued: 429.62m
  • Volume: 327,031
  • Market Cap: £2.31m
  • Beta: 0.89

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
11-Sep-18 Northland Capital Partners Buy 15.75p - 113.00p Reiteration
27-Jul-18 Northland Capital Partners Buy 17.00p - 113.00p Reiteration
11-Jun-18 Northland Capital Partners Buy 22.10p - 113.00p Reiteration
04-May-18 Northland Capital Partners Buy 19.00p 113.00p 113.00p Reiteration
05-Mar-18 Northland Capital Partners Corporate 14.75p - - Reiteration
04-Jan-16 Northland Capital Partners Buy 23.25p - 79.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.54p
Change Today 0.013p
% Change 2.38 %
52 Week High 1.85
52 Week Low 0.52
Volume 327,031
Shares Issued 429.62m
Market Cap £2.31m
Beta 0.89

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.82% below the market average14.82% below the market average14.82% below the market average14.82% below the market average14.82% below the market average
72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average
Price Trend
86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average
79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average
Income Not Available
Growth
17.33% below the market average17.33% below the market average17.33% below the market average17.33% below the market average17.33% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

Theracryf Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
11:22 3,369 @ 0.52p
10:04 210,000 @ 0.53p
08:33 100,000 @ 0.55p
08:31 13,662 @ 0.55p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page